FilingIndex
← The Wire
AVXLNasdaq

ANAVEX LIFE SCIENCES CORP.

Biological Products, (No Diagnostic Substances) · CIK 1314052

Develops precision medicine therapeutics for CNS diseases by targeting sigma-1 receptors to restore cellular homeostasis

red 8-K · 90d
$232M
Market cap
$2.60
Last close
-0.8%
1D
+2.4%
5D
797K
Volume
Price · last 39 sessions-23.8%
May 4L $2.46 · H $3.41Jun 29
252
Total filings
Jun 26, 2026
Last filing
09/30
Fiscal year end
8-KCompany UpdateJun 26, 20268-KDelisting Notice · Company UpdateMay 22, 20268-KExecutive ChangeMay 15, 20268-KExecutive ChangeMay 6, 20268-KCompany UpdateMar 25, 20268-KExecutive Change · Reg FD DisclosureFeb 25, 202610-QFORM 10-QFeb 9, 20268-KResults of OperationsFeb 9, 202610-KFORM 10-KNov 25, 20258-KResults of OperationsNov 25, 20258-KCompany UpdateNov 14, 202510-QFORM 10-QAug 12, 20258-KMaterial AgreementJul 28, 2025424B5FORM 424B5Jul 25, 20258-KExecutive ChangeJul 3, 20258-KExecutive Change · Shareholder VoteJun 13, 202510-QFORM 10-QMay 13, 2025DEFA14AFORM DEFA14AApr 25, 2025DEF 14AFORM DEF 14AApr 25, 202510-QFORM 10-QFeb 12, 202510-KFORM 10-KDec 23, 202410-QFORM 10-QAug 6, 20248-KAgreement TerminatedJul 30, 20248-KShareholder VoteJun 21, 202410-QFORM 10-QMay 9, 20248-KResults of OperationsMay 9, 2024DEFA14AFORM DEFA14AMay 6, 2024DEF 14AFORM DEF 14AMay 6, 202410-QFORM 10-QFeb 7, 202410-KFORM 10-KNov 27, 202310-QFORM 10-QAug 8, 20238-KShareholder VoteMay 24, 202310-QFORM 10-QMay 9, 20238-KBylaw AmendmentApr 14, 2023DEFA14AFORM DEFA14AApr 4, 2023DEF 14AFORM DEF 14AApr 4, 20238-KReg FD DisclosureMar 13, 20238-KCompany UpdateFeb 7, 2023424B5FORM 424B5Feb 7, 202310-QFORM 10-QFeb 7, 202310-K/AFORM 10-K/AJan 27, 20238-KCompany UpdateDec 2, 202210-KFORM 10-KNov 28, 202210-QFORM 10-QAug 9, 20228-KShareholder VoteMay 27, 202210-QFORM 10-QMay 10, 2022DEFA14AFORM DEFA14AApr 11, 2022DEF 14AFORM DEF 14AApr 11, 20228-KExecutive ChangeApr 8, 20228-KAuditor Change · Executive ChangeMar 4, 2022SC 13GSC 13GFeb 9, 202210-QFORM 10-QFeb 9, 2022SC 13GSCHEDULE 13GFeb 9, 20228-KCompany UpdateFeb 4, 20228-KReg FD DisclosureFeb 2, 202210-KFORM 10-KNov 24, 20218-KCompany UpdateSep 27, 20218-KReg FD DisclosureSep 13, 202110-QFORM 10-QAug 12, 20218-KMaterial AgreementJun 24, 2021424B5FORM 424B5Jun 24, 20218-KBylaw Amendment · Shareholder VoteMay 28, 202110-Q10-QMay 13, 2021DEF 14ADEF 14AApr 12, 2021424B5424B5Feb 16, 202110-QFORM 10-QFeb 16, 2021SC 13GSC 13GFeb 2, 20218-KResults of OperationsDec 28, 202010-KFORM 10-KDec 28, 20208-KReg FD Disclosure · Company UpdateDec 15, 20208-KCompany UpdateNov 6, 20208-KReg FD Disclosure · Company UpdateOct 15, 202010-QFORM 10-QAug 6, 20208-KMaterial AgreementJul 2, 2020424B5424B5Jul 2, 202010-QFORM 10-QMay 7, 20208-KMaterial Agreement · Company UpdateMay 1, 2020424B5424B5May 1, 2020424B5424B5May 1, 20208-KShareholder VoteApr 8, 2020

Similar companies

Comparable business profile · signals at a glance